Eastwood Bio-Medical Canada Profit Margin

Eastwood Bio-Medical Canada (EBM.V) currently reports a profit margin of -74.09% as of July 2024. That compares with -36.14% in the prior-year period — down 105.0% year over year. That is below the sector sector average of 13.2%. Use the charts on this page to explore Eastwood Bio-Medical Canada's profit margin history and peer comparisons.

Eastwood Bio-Medical Canada's profit margin decreased from -36.14% to -74.09% — a 105.0% year-over-year decrease (period ending July 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eastwood Bio-Medical Canada's profit margin of -74.09% is lower than the its sector sector average of 13.2%. That is roughly 661.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Eastwood Bio-Medical Canada's current -74.09% should be judged against industry norms (sector average: 13.2%) and against EBM.V's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -74.09%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for Eastwood Bio-Medical Canada, and consider following EBM.V for alerts when major investors trade the stock.